AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2010
Dec 21, 2010
30291_dirs_2010-12-21_e088976c-a87d-4cb4-8aeb-959074abe70d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2010-12-17
Reporting Person: SCHNEIER CRAIG ERIC (EVP, HR, Public Affairs & Comm)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-12-17 | Common Stock | M | 19450 | $49.31 | Acquired | 40566.2794 | Direct |
| 2010-12-17 | Common Stock | S | 19450 | $68.20 | Disposed | 21116.2794 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-12-17 | Stock Option (Right to Buy) | $49.31 | M | 19450 | Disposed | 2017-02-11 | Common Stock (19450) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 460 | Indirect |
Footnotes
F1: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
F3: The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/12/07.
More from BIOGEN INC.
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Apr 7
Regulatory Filings
2026
Apr 6